Palanisamy Arulselvan

6.7k citations
156 papers · 5.3k indexed · 1 hit paper · h-index 42
Topics
Nanoparticle-Based Drug Delivery (27 papers)Nanoparticles: synthesis and applications (21 papers)Moringa oleifera research and applications (18 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEScientific Reports

In The Last Decade

Palanisamy Arulselvan

147 papers receiving 5.1k citations

Hit Papers

Role of Antioxidants and Natural Products in Inflammation20162026201920222016250500750

Peers

Palanisamy Arulselvan
Comparison fields: 5 of 154
  • Plant Science 1.3k
  • Molecular Biology 1.0k
  • Materials Chemistry 793
  • Endocrinology, Diabetes and Metabolism 777
  • Pharmacology 699
Replace Sharida Fakurazi with:
Sharida Fakurazi Malaysia
Ligen Lin Macao
Mahmood Ameen Abdulla Malaysia
Esra Küpeli Akkol Türkiye
Ganesh Chandra Jagetia India
Muhammad Imran Pakistan
Syed Nasir Abbas Bukhari Saudi Arabia
Shailendra Saraf India
Sreenivasan Sasidharan Malaysia
Ali Talha Khalil Pakistan
Palanisamy Arulselvan relative to Sharida Fakurazi Malaysia Sharida Fakurazi's profile →
Citations per field
00.5×1.6×
Sharida Fakurazi · 1×
Citations per year

Countries citing papers authored by Palanisamy Arulselvan

Since Specialization
Citations

This map shows the geographic impact of Palanisamy Arulselvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Palanisamy Arulselvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Palanisamy Arulselvan more than expected).

Fields of papers citing papers by Palanisamy Arulselvan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Palanisamy Arulselvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Palanisamy Arulselvan. The network helps show where Palanisamy Arulselvan may publish in the future.

Co-authorship network of co-authors of Palanisamy Arulselvan

This figure shows the co-authorship network connecting the top 25 collaborators of Palanisamy Arulselvan. A scholar is included among the top collaborators of Palanisamy Arulselvan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Palanisamy Arulselvan. Palanisamy Arulselvan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 3
3 0
4 3
5 6
6 3
7 6
8 3
9 10
10 26
11 28
12 122
13 102
14 30
15 2
16 12
17 48
18 102
19
Role of Antioxidants and Natural Products in Inflammationbreakdown →
774
20 2

About Palanisamy Arulselvan

Palanisamy Arulselvan is a scholar working on Biomaterials, Molecular Medicine and Complementary and alternative medicine, having authored 156 papers that have together received 5.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (27 papers), Nanoparticles: synthesis and applications (21 papers) and Moringa oleifera research and applications (18 papers). The work is most often cited by research in Pharmacology (699 citations), Biochemistry (468 citations) and Complementary and alternative medicine (614 citations). Palanisamy Arulselvan has collaborated with scholars based in Malaysia, India and Saudi Arabia. Frequent co-authors include Sharida Fakurazi, Sivapragasam Gothai, Mohd Zobir Hussein, Woan Sean Tan, Suresh Kumar, Mohd Esa Norhaizan, S. Subramanian, Govindarajan Karthivashan, Faridah Abas and Farahnaz Barahuie. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026